Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More
Xconomy
OCTOBER 7, 2016
The firm will now focus on its miniLab, which CEO Elizabeth Holmes touted as a follow-on version of its Edison test system at a scientific conference in August. The funding could be as much as $100 million, and the first grants will be announced in 2017. . She refused to discuss Edison at the time. —The U.S. CLINICAL NEWS.
77 
Let's personalize your content